Claas FH - Search Results

1

ABH antibodies causing platelet transfusion refractoriness.

Brand A, Sintnicolaas K, Claas FH, Eernisse JG. Brand A, et al. Among authors: claas fh. Transfusion. 1986 Sep-Oct;26(5):463-6. doi: 10.1046/j.1537-2995.1986.26587020127.x. Transfusion. 1986. PMID: 3532447

2

HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies.

Schonewille H, Doxiadis II, Levering WH, Roelen DL, Claas FH, Brand A. Schonewille H, et al. Among authors: claas fh. Transfusion. 2014 Aug;54(8):1971-80. doi: 10.1111/trf.12624. Epub 2014 Mar 24. Transfusion. 2014. PMID: 24654685

3

UV-irradiated platelets: ready to use?

Brand A, Claas FH, van Rood JJ. Brand A, et al. Among authors: claas fh. Transfusion. 1989 Jun;29(5):377-8. doi: 10.1046/j.1537-2995.1989.29589284133.x. Transfusion. 1989. PMID: 2734818 No abstract available.

4

Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.

Brand A, Claas FH, Voogt PJ, Wasser MN, Eernisse JG. Brand A, et al. Among authors: claas fh. Vox Sang. 1988;54(3):160-6. doi: 10.1111/j.1423-0410.1988.tb03892.x. Vox Sang. 1988. PMID: 3369136

5

Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.

Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A. Sintnicolaas K, et al. Among authors: claas fh. Blood. 1995 Feb 1;85(3):824-8. Blood. 1995. PMID: 7833483 Free article. Clinical Trial.

6

Beneficial effect of intravenous gammaglobulin in a patient with complement-mediated autoimmune thrombocytopenia due to IgM-anti-platelet antibodies.

Brand A, Witvliet M, Claas FH, Eernisse JG. Brand A, et al. Among authors: claas fh. Br J Haematol. 1988 Aug;69(4):507-11. doi: 10.1111/j.1365-2141.1988.tb02407.x. Br J Haematol. 1988. PMID: 3408686

7

The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response.

Waanders MM, Roelen DL, Brand A, Claas FH. Waanders MM, et al. Among authors: claas fh. Transfus Med Rev. 2005 Oct;19(4):281-7. doi: 10.1016/j.tmrv.2005.04.002. Transfus Med Rev. 2005. PMID: 16214017 Review.

8

High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.

Verduin EP, Schonewille H, Brand A, Haasnoot GW, Claas FH, Lindenburg IT, Lopriore E, Oepkes D, Roelen DL, Doxiadis II. Verduin EP, et al. Among authors: claas fh. Transfusion. 2013 May;53(5):939-47. doi: 10.1111/j.1537-2995.2012.03862.x. Epub 2012 Aug 23. Transfusion. 2013. PMID: 22924899 Clinical Trial.

9

Blood component therapy in bone marrow transplantation.

Brand A, Claas FH, Falkenburg JH, van Rood JJ, Eernisse JG. Brand A, et al. Among authors: claas fh. Semin Hematol. 1984 Apr;21(2):141-55. Semin Hematol. 1984. PMID: 6330905 Review. No abstract available.

10

Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.

Claas FH, Smeenk RJ, Schmidt R, van Steenbrugge GJ, Eernisse JG. Claas FH, et al. Exp Hematol. 1981 Jan;9(1):84-9. Exp Hematol. 1981. PMID: 7238645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

705 results

Search Page